These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 11199945)

  • 1. Augmentation of fluoxetine's antidepressant action by pindolol: analysis of clinical, pharmacokinetic, and methodologic factors.
    Pérez V; Puiigdemont D; Gilaberte I; Alvarez E; Artigas F;
    J Clin Psychopharmacol; 2001 Feb; 21(1):36-45. PubMed ID: 11199945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel Augmentation Strategies in Major Depression.
    Martiny K
    Dan Med J; 2017 Apr; 64(4):. PubMed ID: 28385173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomised, double-blind, placebo-controlled trial of pindolol in combination with fluoxetine antidepressant treatment.
    Pérez V; Gilaberte I; Faries D; Alvarez E; Artigas F
    Lancet; 1997 May; 349(9065):1594-7. PubMed ID: 9174562
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pindolol augmentation enhances response outcomes in first depressive episodes.
    Portella MJ; de Diego-Adeliño J; Puigdemont D; Pérez-Egea R; Alvarez E; Artigas F; Pérez V
    Eur Neuropsychopharmacol; 2009 Jul; 19(7):516-9. PubMed ID: 19419845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pindolol and mianserin augment the antidepressant activity of fluoxetine in hospitalized major depressed patients, including those with treatment resistance.
    Maes M; Libbrecht I; van Hunsel F; Campens D; Meltzer HY
    J Clin Psychopharmacol; 1999 Apr; 19(2):177-82. PubMed ID: 10211920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How long should pindolol be associated with paroxetine to improve the antidepressant response?
    Zanardi R; Artigas F; Franchini L; Sforzini L; Gasperini M; Smeraldi E; Perez J
    J Clin Psychopharmacol; 1997 Dec; 17(6):446-50. PubMed ID: 9408806
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-effectiveness of fluoxetine plus pindolol in patients with major depressive disorder: results from a randomized, double-blind clinical trial.
    Sacristán JA; Gilaberte I; Boto B; Buesching DP; Obenchain RL; Demitrack M; Pérez Sola V; Alvarez E; Artigas F
    Int Clin Psychopharmacol; 2000 Mar; 15(2):107-13. PubMed ID: 10759342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of treatment with trazodone in combination with pindolol or fluoxetine in major depression.
    Maes M; Vandoolaeghe E; Desnyder R
    J Affect Disord; 1996 Dec; 41(3):201-10. PubMed ID: 8988452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of pindolol in hastening response to fluoxetine in the treatment of major depression: a double-blind, placebo-controlled trial.
    Berman RM; Darnell AM; Miller HL; Anand A; Charney DS
    Am J Psychiatry; 1997 Jan; 154(1):37-43. PubMed ID: 8988956
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Interest of the use of pindolol in the treatment of depression: review].
    Brousse G; Schmitt A; Chereau I; Eschalier A; Dubray C; Llorca PM
    Encephale; 2003; 29(4 Pt 1):338-50. PubMed ID: 14615704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Can we really accelerate and enhance the selective serotonin reuptake inhibitor antidepressant effect? A randomized clinical trial and a meta-analysis of pindolol in nonresistant depression.
    Portella MJ; de Diego-Adeliño J; Ballesteros J; Puigdemont D; Oller S; Santos B; Álvarez E; Artigas F; Pérez V
    J Clin Psychiatry; 2011 Jul; 72(7):962-9. PubMed ID: 21034693
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Milnacipran and pindolol: a randomized trial of reduction of antidepressant latency.
    Isaac MT; Isaac MB; Gallo F; Tournoux A
    Hum Psychopharmacol; 2003 Dec; 18(8):595-601. PubMed ID: 14696018
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of pindolol with fluoxetine in the treatment of major depression: final results from a double-blind, placebo-controlled trial.
    Berman RM; Anand A; Cappiello A; Miller HL; Hu XS; Oren DA; Charney DS
    Biol Psychiatry; 1999 May; 45(9):1170-7. PubMed ID: 10331109
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of trazodone and fluoxetine in the treatment of major depression: therapeutic pharmacokinetic and pharmacodynamic interactions through formation of meta-chlorophenylpiperazine.
    Maes M; Westenberg H; Vandoolaeghe E; Demedts P; Wauters A; Neels H; Meltzer HY
    J Clin Psychopharmacol; 1997 Oct; 17(5):358-64. PubMed ID: 9315986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pindolol augmentation of selective serotonin reuptake inhibitors: accounting for the variability of results of placebo-controlled double-blind studies in patients with major depression.
    Segrave R; Nathan PJ
    Hum Psychopharmacol; 2005 Apr; 20(3):163-74. PubMed ID: 15648095
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Addition of the alpha2-antagonist yohimbine to fluoxetine: effects on rate of antidepressant response.
    Sanacora G; Berman RM; Cappiello A; Oren DA; Kugaya A; Liu N; Gueorguieva R; Fasula D; Charney DS
    Neuropsychopharmacology; 2004 Jun; 29(6):1166-71. PubMed ID: 15010697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pindolol augmentation in patients with treatment-resistant panic disorder: A double-blind, placebo-controlled trial.
    Hirschmann S; Dannon PN; Iancu I; Dolberg OT; Zohar J; Grunhaus L
    J Clin Psychopharmacol; 2000 Oct; 20(5):556-9. PubMed ID: 11001241
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination of antidepressant medications from treatment initiation for major depressive disorder: a double-blind randomized study.
    Blier P; Ward HE; Tremblay P; Laberge L; Hébert C; Bergeron R
    Am J Psychiatry; 2010 Mar; 167(3):281-8. PubMed ID: 20008946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does Curcumin or Pindolol Potentiate Fluoxetine's Antidepressant Effect by a Pharmacokinetic or Pharmacodynamic Interaction?
    Murad HA; Suliaman MI; Abdallah H; Abdulsattar M
    Indian J Pharm Sci; 2014 May; 76(3):203-10. PubMed ID: 25035531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preliminary randomized double-blind placebo-controlled trial of tryptophan combined with fluoxetine to treat major depressive disorder: antidepressant and hypnotic effects.
    Levitan RD; Shen JH; Jindal R; Driver HS; Kennedy SH; Shapiro CM
    J Psychiatry Neurosci; 2000 Sep; 25(4):337-46. PubMed ID: 11022398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.